Dawn Richards, Ph.D., is the founder of Five02 Labs Inc., and Director of Patient and Public Engagement at Clinical Trials Ontario. With a Ph.D. (Analytical Chemistry) from the University of Alberta and experience in a variety of roles during the past 20 years, it is her diagnosis of rheumatoid arthritis in 2006 that started her journey to combine her passion for science with making the most of her diagnosis.
In her role as CTO, Dawn is charged with executing on CTO’s strategic pillar of patient and public engagement.